In the BioHarmony Drug Report Database

"Preview" Icon

Doxycycline

Monodox, Oracea, Vibramycin (doxycycline) is a small molecule pharmaceutical. Doxycycline was first approved as Monodox on 1982-01-01. It is used to treat anthrax, bacterial pneumonia, campylobacter infections, cholera, and granuloma inguinale amongst others in the USA. The pharmaceutical is active against matrilysin. In addition, it is known to target neutrophil collagenase. Doxycycline hyclate’s patents are valid until 2027-12-19 (FDA).

 

Trade Name

 

Monodox, Oracea, Vibramycin
 

Common Name

 

doxycycline
 

ChEMBL ID

 

CHEMBL1433
 

Indication

 

anthrax, bacterial pneumonia, campylobacter infections, cholera, granuloma inguinale, mycoplasma infections, plague, pleural effusion, psittacosis, relapsing fever, rocky mountain spotted fever, syphilis, trachoma
 

Drug Class

 

Antibiotics (tetracycline derivatives)

Image (chem structure or protein)

Doxycycline structure rendering